Tacrolimus USP (Monohydrate) For Compounding (API)

Tacrolimus USP (Monohydrate) is an active pharmaceutical ingredient (API) used in the formulation of medications to treat various inflammatory and autoimmune diseases. It belongs to a class of drugs called calcineurin inhibitors and works by suppressing the immune system to prevent rejection of transplanted organs and to treat conditions such as eczema, psoriasis, and rheumatoid arthritis. The USP designation indicates that it meets the standards set by the United States Pharmacopeia for purity, quality, strength, and identity. The monohydrate form of this API contains one molecule of water per molecule of tacrolimus and is preferred in certain formulations for its stability and solubility properties.

Tacrolimus USP (Monohydrate) for compounding is a pharmaceutical ingredient used in the preparation of compounded medications. It is used as an immunosuppressant agent to prevent organ rejection in patients who have received a transplant. Tacrolimus works by suppressing the activity of the immune system and preventing it from attacking the transplanted organ. This medication is often used in combination with other drugs to treat conditions such as kidney, liver, and heart transplants, as well as autoimmune disorders such as eczema and psoriasis.

CAS Number: 109581-93-3
Property: Light Sensitive | Hazardous Material